These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11428934)

  • 21. A molecular model of myelin oligodendrocyte glycoprotein.
    Hjelmström P; Penzotti JE; Henne RM; Lybrand TP
    J Neurochem; 1998 Oct; 71(4):1742-9. PubMed ID: 9751210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein.
    O'Connor KC; Appel H; Bregoli L; Call ME; Catz I; Chan JA; Moore NH; Warren KG; Wong SJ; Hafler DA; Wucherpfennig KW
    J Immunol; 2005 Aug; 175(3):1974-82. PubMed ID: 16034142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein.
    Lindert RB; Haase CG; Brehm U; Linington C; Wekerle H; Hohlfeld R
    Brain; 1999 Nov; 122 ( Pt 11)():2089-100. PubMed ID: 10545394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
    Kerlero de Rosbo N; Hoffman M; Mendel I; Yust I; Kaye J; Bakimer R; Flechter S; Abramsky O; Milo R; Karni A; Ben-Nun A
    Eur J Immunol; 1997 Nov; 27(11):3059-69. PubMed ID: 9394837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis.
    Menge T; Lalive PH; von Büdingen HC; Genain CP
    J Neuroinflammation; 2011 Nov; 8():161. PubMed ID: 22093619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISA.
    Menge T; von Büdingen HC; Lalive PH; Genain CP
    Eur J Immunol; 2007 Nov; 37(11):3229-39. PubMed ID: 17918203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases.
    Mazzucco S; Matà S; Vergelli M; Fioresi R; Nardi E; Mazzanti B; Chelli M; Lolli F; Ginanneschi M; Pinto F; Massacesi L; Papini AM
    Bioorg Med Chem Lett; 1999 Jan; 9(2):167-72. PubMed ID: 10021921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy.
    Angelucci F; Mirabella M; Frisullo G; Caggiula M; Tonali PA; Batocchi AP
    Dis Markers; 2005; 21(2):49-55. PubMed ID: 15920290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies.
    Abo S; Bernard CC; Webb M; Johns TG; Alafaci A; Ward LD; Simpson RJ; Kerlero de Rosbo N
    Biochem Mol Biol Int; 1993 Aug; 30(5):945-58. PubMed ID: 8220243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination.
    Ramanathan S; Dale RC; Brilot F
    Autoimmun Rev; 2016 Apr; 15(4):307-24. PubMed ID: 26708342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.
    Lalive PH; Menge T; Delarasse C; Della Gaspera B; Pham-Dinh D; Villoslada P; von Büdingen HC; Genain CP
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2280-5. PubMed ID: 16461459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucopeptides derived from myelin-relevant proteins and hyperglucosylated nontypeable Haemophilus influenzae bacterial adhesin cross-react with multiple sclerosis specific antibodies: A step forward in the identification of native autoantigens in multiple sclerosis.
    Quagliata M; Nuti F; Real-Fernandez F; Kirilova Kirilova K; Santoro F; Carotenuto A; Papini AM; Rovero P
    J Pept Sci; 2023 Jul; 29(7):e3475. PubMed ID: 36597597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myelin oligodendrogliocyte glycoprotein: the structure, functions, role in pathogenesis of demyelinating disorders].
    Chekhonin VP; Semenova AV; Gurina OI; Dmitrieva TB
    Biomed Khim; 2003; 49(5):411-23. PubMed ID: 16119093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
    Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
    Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55.
    Ichikawa M; Johns TG; Liu J; Bernard CC
    J Immunol; 1996 Jul; 157(2):919-26. PubMed ID: 8752946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
    Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
    Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis.
    Karni A; Bakimer-Kleiner R; Abramsky O; Ben-Nun A
    Arch Neurol; 1999 Mar; 56(3):311-5. PubMed ID: 10190821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein.
    Breithaupt C; Schubart A; Zander H; Skerra A; Huber R; Linington C; Jacob U
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9446-51. PubMed ID: 12874380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.
    Kerlero de Rosbo N; Milo R; Lees MB; Burger D; Bernard CC; Ben-Nun A
    J Clin Invest; 1993 Dec; 92(6):2602-8. PubMed ID: 7504688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.